137 related articles for article (PubMed ID: 10622562)
1. Clinical implications of hepatitis C viral kinetics.
Zeuzem S
J Hepatol; 1999; 31 Suppl 1():61-4. PubMed ID: 10622562
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus kinetics.
Herrmann E; Neumann AU; Schmidt JM; Zeuzem S
Antivir Ther; 2000 Jun; 5(2):85-90. PubMed ID: 10971860
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of hepatitis C virus infection.
Zeuzem S; Herrmann E
Ann Hepatol; 2002; 1(2):56-63. PubMed ID: 15115969
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy.
Zeuzem S
Forum (Genova); 2000; 10(1):32-42. PubMed ID: 10717256
[TBL] [Abstract][Full Text] [Related]
5. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
[TBL] [Abstract][Full Text] [Related]
6. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
[TBL] [Abstract][Full Text] [Related]
7. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen.
Lunel F; Veillon P; Fouchard-Hubert I; Loustaud-Ratti V; Abergel A; Silvain C; Rifflet H; Blanchi A; Causse X; Bacq Y; Payan C;
J Hepatol; 2003 Nov; 39(5):826-33. PubMed ID: 14568267
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
10. Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy.
Bekkering FC; Brouwer JT; Leroux-Roels G; Van Vlierberghe H; Elewaut A; Schalm SW
J Hepatol; 1998 Jun; 28(6):960-4. PubMed ID: 9672170
[TBL] [Abstract][Full Text] [Related]
11. Effects of ribavirin combined with interferon-alpha 2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads.
Enomoto M; Nishiguchi S; Kohmoto M; Tamori A; Habu D; Takeda T; Seki S; Shiomi S
J Viral Hepat; 2004 Sep; 11(5):448-54. PubMed ID: 15357651
[TBL] [Abstract][Full Text] [Related]
12. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of hepatitis C virus infection.
Zeuzem S
Clin Liver Dis; 2001 Nov; 5(4):917-30. PubMed ID: 11685801
[TBL] [Abstract][Full Text] [Related]
14. Quantification of serum hepatitis C virus RNA with daily or standard interferon doses plus ribavirin in nonresponder patients with chronic hepatitis C.
Buti M; Olive G; Stalgis C; Esteban R; Guardi J
Dig Dis Sci; 2000 Apr; 45(4):685-9. PubMed ID: 10759235
[TBL] [Abstract][Full Text] [Related]
15. Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy.
Derbala MF; El Dweik NZ; Al Kaabi SR; Al-Marri AD; Pasic F; Bener AB; Shebl FM; Amer AM; Butt MT; Yakoob R; John A; Al Mohanadi M; Al Khinji MA
J Viral Hepat; 2008 Aug; 15(8):591-9. PubMed ID: 18482284
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patients.
Fujita N; Kaito M; Tanaka H; Horiike S; Urawa N; Sugimoto R; Konishi M; Watanabe S; Adachi Y
J Viral Hepat; 2006 Mar; 13(3):190-8. PubMed ID: 16475995
[TBL] [Abstract][Full Text] [Related]
17. First phase hepatitis c viral kinetics in previous nonresponders patients.
Cotler SJ; Layden JE; Neumann AU; Jensen DM
J Viral Hepat; 2003 Jan; 10(1):43-9. PubMed ID: 12558911
[TBL] [Abstract][Full Text] [Related]
18. Viral dynamics and pharmacokinetics in combined interferon alfa-2b and ribavirin therapy for patients infected with hepatitis C virus of genotype 1b and high pretreatment viral load.
Tsubota A; Akuta N; Suzuki F; Suzuki Y; Someya T; Kobayashi M; Arase Y; Saitoh S; Ikeda K; Kumada H
Intervirology; 2002; 45(1):33-42. PubMed ID: 11937769
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response.
Carlsson T; Reichard O; Norkrans G; Bläckberg J; Sangfelt P; Wallmark E; Weiland O
J Viral Hepat; 2005 Sep; 12(5):473-80. PubMed ID: 16108761
[TBL] [Abstract][Full Text] [Related]
20. Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon alpha-2b and ribavirin.
Gallegos-Orozco JF; Loaeza-del Castillo A; Fuentes AP; García-Sandoval M; Soto L; Rodríguez R; Gutiérrez-Ruíz MC; Gutiérrez-Reyes G; Bonder A; Olivera MA; Kershenobich D
Liver Int; 2005 Feb; 25(1):91-5. PubMed ID: 15698404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
